JPRN-jRCTb030190222已完成1 期
Alveolar bone regeneration therapy using autologous bone marrow stromal cells - Alveolar bone regenration using bone marrow stromal cells
Kagami Hideaki0 个研究点目标入组 3 人开始时间: 2020年2月7日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 3
研究概览
简要总结
Through the cases, bone tissue engineering by a novel protocol using an automated cell culture device showed the efficacy comparable to that of the conventional protocol by hands, thus it is assumed as an effective method to regenerate alveolar bone.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 70age old（—）
- 性别
- All
入选标准
- •Subjects were patients who planned to receive dental implant treatment. These subjects had continuous tooth defects (more than 2), where fixed prostheses were not applicable. The subjects voluntarily enrolled in this study and wished to have dental implant treatment rather than conventional removable prostheses. Subjects showed severely atrophic maxilla or mandible, which require bone transplantation. The width of alveolar bone at the installation sites was less than 5 mm. In the maxilla, the distance between the alveolar ridge and the sinus floors was less than 5 mm. Similarly, in the mandible, the distance between the ridge and mandibular canal was less than 5 mm. Good oral hygiene was maintained. Tooth brushing instruction and scaling were performed prior to the protocol treatment. The age of the subjects was limited to 20 -70 years. The subjects were able to understand and agreed to receive the treatment by informed consent.
排除标准
- •Patients with diabetes and/or autoimmune diseases, who presented hemorrhagic diathesis where partial thromboplastin time (PT) was lower than 50% and activated partial thromboplastin time (APTT) less than 23.5 or longer than 42.5 seconds, uncontrollable infectious diseases, patients with osteoporosis who are prescribed bisphosphonate, liver dysfunction with a Glutamic Oxaloacetic Transaminase (GOT) value less than 10 or more than 40 IU/L or with a glutamic pyruvic transaminase (GPT) less than 5 or more than 45 IU/L, pregnant or possible pregnancy, allergy to any of the medications used in this study and/or the presence of allergy that required continuous systemic medication, smokers, subjects who are positive for HBs antigen (CLIA), HBs antibody (CLIA), HBc antigen (CLIA), HCV antibody (RIA solid phase), HIV antigen and HIV antibody (ELISAs), syphilis serology (RPR), syphilis serology (TPHA) and HTLV-1 and other special conditions that the responsible physician considered not appropriate were excluded.
研究者
相似试验
已完成
3 期
Bone Tissue Engineering With Dental Pulp Stem Cells for Alveolar Cleft RepairCleft Lip and PalateNCT03766217Hospital Sirio-Libanes62
已完成
1 期
Alveolar bone regeneration therapy using autologous bone marrow stromal cellsAlveolar bone atrophyJPRN-UMIN000033847Matsumoto Dental University Hospital3
已完成
1 期
Alveolar bone regeneration with non-cultured autologous adipose cells (Phase I clinical study)Severe alveolar bone atrophyJPRN-UMIN000027268Department of Regenerative Oral Surgely, Nagasaki University Graduate School of Biomediacal Sciences15
暂停
1 期
Alveolar bone regeneration with fresh isolated adipose stem/progenitor cellsJPRN-jRCTb070190059Asahina Izumi15
已完成
不适用
Bone regeneration for alveolar bone regeneration using platelet rich plasmabone defectJPRN-UMIN000012596Osaka Medical College30